Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker.

Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker. J Clin Pharmacol. 1988 Mar; 28(3):276-82.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.